Dimensional Fund Advisors LP Night Hawk Biosciences, Inc. Transaction History

Dimensional Fund Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.77 - $1.62 $12,696 - $26,712	-16,489 Reduced 18.4%	73,132 $59,000
Q3 2022 Nov 10, 2022	SELL	$1.79 - $2.96 $24,385 - $40,324	-13,623 Reduced 13.19%	89,621 $160,000
Q2 2022 Aug 12, 2022	BUY	$1.65 - $3.13 $45,653 - $86,603	27,669 Added 36.61%	103,244 $257,000
Q1 2022 May 13, 2022	SELL	$2.1 - $3.54 $5,214 - $8,789	-2,483 Reduced 3.18%	75,575 $234,000
Q4 2021 Feb 09, 2022	BUY	$3.04 - $6.01 $84,402 - $166,861	27,764 Added 55.2%	78,058 $237,000
Q3 2021 Nov 12, 2021	BUY	$5.9 - $7.44 $296,734 - $374,187	50,294 New	50,294 $299,000

48.5K

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.